Press release
Use of Extended Reality to Drive the Dermatophytic Onychomycosis Therapeutics Market
The global dermatophytic onychomycosis therapeutics (DOT) market is anticipated to expand at a healthy CAGR of around 7% during the forecast period. The market is expected to be worth US$ 8.9 Bn by the end of this decade, increasing from US$ 4.6 Bn in 2021.
By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR during the forecast period.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5840
By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for over 3/5 share of the total global dermatophytic onychomycosis market revenue by 2021.
By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 2/5 share of the total global market revenue by 2021-end.
Company Profiles:
Valeant Pharmaceuticals Inc.
Galderma S.A.
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Johnson & Johnson Services, Inc.
Bayer AG
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Medimetriks Pharmaceuticals, Inc.
Others.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5840
The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2021-end.
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.
However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5840
This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for nearly 50% revenue share of the total dermatophytic onychomycosis therapeutics market by 2021-end, i.e. holding the maximum market share. Whereas Europe is projected to grow at a healthy CAGR due to increasing awareness about fungal nail infections.
Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/dermatophytic-onychomycosis-therapeutics-market.asp
All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights.
Related Reports:
Immunooncology Market - https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp
Biopharmaceutical Market - https://www.persistencemarketresearch.com/market-research/biopharmaceutical-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Use of Extended Reality to Drive the Dermatophytic Onychomycosis Therapeutics Market here
News-ID: 2571877 • Views: …
More Releases from Persistence Market Research
Nanomaterials Market Valued at US$ 22.1 Billion in 2025, Poised to Reach US$ 69. …
The nanomaterials market has entered a phase of accelerated commercialization, driven by technological maturity and growing demand across sectors. The market's rapid expansion is supported by rising investments in research and development, improved synthesis techniques, and the ability to mass-produce high-quality nanomaterials at reduced costs.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33646
By 2025, the market will reach an estimated valuation of…
Mycotoxin Testing Market Value to Reach US$ 3,268.6 Mn by 2032 Driven by Food Sa …
The global mycotoxin testing market is witnessing robust growth, driven by the increasing need for food safety and quality assurance across agricultural and food production sectors. Valued at US$ 2,145.3 million in 2025, the market is projected to reach approximately US$ 3,268.6 million by 2032, expanding at a steady compound annual growth rate (CAGR) of 6.2% during the forecast period (2025-2032). This growth is primarily attributed to the rising awareness…
Natural Health Supplements Market to Reach $112.8 Bn by 2032 Driven by Wellness …
The global natural health supplements market is set for robust expansion, reflecting the world's growing inclination toward wellness, preventive healthcare, and clean-label nutritional products. The market is projected to reach a valuation of US$ 66.7 billion in 2025 and is expected to exhibit a healthy compound annual growth rate (CAGR) of 7.8% during the forecast period from 2025 to 2032. By the end of 2032, the market is anticipated to…
Pet Snacks and Treats Market Value to Reach $19.5 Bn by 2030 Driven by Rising Pe …
The global pet snacks and treats market is poised for notable growth over the coming years, expanding from a valuation of US$13.3 billion in 2023 to an estimated US$19.5 billion by the end of 2030. The market is forecast to grow at a compound annual growth rate (CAGR) of 5.6% during the period from 2023 to 2030. This consistent growth trajectory is primarily attributed to rising pet ownership rates, increasing…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…
